Eledon pharmaceuticals appoints kidney transplant specialist dr. allan douglas kirk to board of directors

Irvine, calif., oct. 02, 2023 (globe newswire) -- eledon pharmaceuticals, inc. (“eledon”) (nasdaq: eldn) today announced the appointment of allan douglas kirk, m.d.

ELDN Ratings Summary

ELDN Quant Ranking